Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Medical Devices

Background:

• Ovarian and fallopian tube cancers often spread within the peritoneal cavity.
• This pattern makes patients potential candidates for intraperitoneal (IP) therapy.

Purpose of the Study:

• To evaluate the safety and efficacy of implanted Port-A-Cath systems for IP therapy in gynecologic malignancies.
• To analyze catheter function, complications, and management strategies.

Main Methods:

• Retrospective review of 106 patients receiving IP therapy via Port-A-Cath systems.
• Data collected included patient characteristics, catheter use, function, and complications.
• Analysis of reasons for catheter removal and subsequent management.

Main Results:

• The implanted Port-A-Cath system facilitated multiple IP therapy uses, including chemotherapy, immunotherapy, and ascites drainage.
• Catheter removal occurred for infection (6), poor fluid distribution (2), and non-function (8).
• Overall serious infection rate was 8.5%; major complications were infrequent and manageable.

Conclusions:

• Implanted Port-A-Cath systems are a viable option for delivering IP therapy in gynecologic cancers.
• The system allows for diverse therapeutic applications and manageable complication rates.
• Experience at MSKCC demonstrates the utility of this approach for intra-abdominal disease management.